Jul 31, 2020

Experimental stem cell therapy trial for COVID-19 initiated

Posted by in category: biotech/medical

Researchers announce the first patient has been dosed in a trial testing remestemcel-L, a stem cell therapy, in severe COVID-19 patients on ventilators.

grey coronavirus particle interacting with red and purple stem cell

Testing of an experimental COVID-19 stem cell therapy has begun in the US. The therapy has been developed to treat hospitalised COVID-19 patients with moderate to severe acute respiratory distress syndrome (ARDS) who are on ventilators. A total of 300 are expected to be recruited into the randomised, placebo-controlled trial.

Comments are closed.